RIGL | Rigel Pharmaceuticals Inc. (New)NASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$48.86
-$1.67 (-3.30%)

Rigel Pharmaceuticals Inc. (New) (RIGL) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits above the 50 and the 200; on the 4-hour it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $48.86 vs 50 $47.86 / 200 $37.27
Projection
No cross projected
Test
No active test
Last cross
Golden cross 23 Jul 2026 ยท projected 20 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $51.31 vs 50 $38.20 / 200 $22.13
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 2 Jun 2025 ยท projected 22 bars out ยท tested 5 bars

4-hour as of 3 Nov 13:30 ET

Price
between the two $48.42 vs 50 $48.46 / 200 $43.57
Projection
No cross projected
Test
No active test
Last cross
Golden cross 22 Jun 2026 ยท projected 29 bars out

Cross history

32
crosses on record since 2017
17 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
23 Jul 2026Golden steepdaily20 bars outNot tested
22 Jun 2026Golden4-hour29 bars outNot tested
26 Mar 2026Death steepdaily22 bars outNot tested
12 Feb 2026Death4-hour27 bars out2 bar cross test
25 Jul 2025Golden4-hour11 bars outโ€”

About RIGL

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$9.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.